Personalizing Health
search
Home
Corporate
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Media & Investor Information
Shareholder Information
Corporate Governance
Shareholder Meetings & Notice
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Medical
Overview
Breast & Ovarian Cancer
Bowel & Uterine Cancer
Neurogenetics
Epilepsy
Forensics
Overview
Presumptive & Confirmatory Testing
Individual DNA Profiling
Species Identification
Animal Forensic Testing
Paternity
Legal - Paternity
Non Legal - Paternity
Legal Practitioners
Antenatal
Deceased Estate
DNA In A Day
Sibship
Twins
Y – Chromosome
DNA Profiling
Grandparent
Immigration
Personal
Overview
Sports Performance
Ancestry
Animals
DNA Testing
BITSA
Animal Forensics
Plants
Genomic Services
Xpress Sequencing
About Us
How we got here
What we do
Directors & Management
Directors
Senior Management
Company Information
Reports
Announcements
Media & Investor Information
Shareholder Information
Corporate Governance
Shareholder Meetings & List
Licensing
Introduction
List of Licensees
Research & IP
RareCellect
ImmunAid
Nematode Project
Patent Portfolio
Announcements
Investor presentation at Rodman & Renshaw
13 September 2011
Investor presentation at Rodman & Renshaw
Conference Webcasting
ASX Appendix 4E - 30 June 2011
25 August 2011
ASX Appendix 4E - 30 June 2011
GTG maiden full year profit
25 August 2011
GTG maiden full year profit
Settlement with Attomol GmbH
25 August 2011
Settlement with Attomol GmbH
Placement of shares and ASX Appendix 3B
27 July 2011
Placement of shares and ASX Appendix 3B
Previous Announcements
Cleansing notice
Completion of Successful Capital Raising
Response to Price and Volume Query
Market Update
Genetic Technologies Executes Settlement and License Agreement with Navigenics Inc.
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 4 of 27
Announcements
Passing of Dr. Malcolm Simons
ASX Quarterly Reports - 31 December 2011
ASX share price query and response - 27 January 2012
Latest News
Biotech Daily - The Year in Review - CEO Of The Year Dr Paul MacLeman
GTG Appoints Biotech Doyen Chairman
Ladenburg Thalmann Initiates Research Coverage.
Share Price